Dr Reddy’s Laboratories Limited has launched Palonosetron Hydrochloride Injection, 0.25 mg/ml in US. It has been approved by the US Food and Drug Administration (USFDA) and...
Zydus Cadila, has received final approval from US health regulator to market Dexmedetomidine Hydrochloride injection. The company in a regulatory filing stated that, the approval is...
Dr Reddy’s Laboratories has launched Melphalan Hydrochloride for Injection, a therapeutic equivalent generic version of Alkeran (melphalan hydrochloride) for Injection, in the United States market. This...